Tuo, Jia-Yi
Shen, Qiu-Ming
Li, Zhuo-Ying
Tan, Jing-Yu
Fang, Jie
Gao, Li-Feng
Tan, Yu-Ting
Li, Hong-Lan
Xiang, Yong-Bing
Funding for this research was provided by:
National Key Project of Research and Development Program of China (2021YFC2500404, 2021YFC2500405)
US National Institutes of Health (UM1 CA182910 (subcontract))
Article History
Received: 15 November 2023
Accepted: 11 April 2024
First Online: 29 April 2024
Declarations
:
: The authors declare no competing interests.
: The cohort protocol has been approved by the Institutional Review Boards of the Shanghai Cancer Institute and Vanderbilt University. Informed consent has been obtained from all participants. The current study has been approved by the Renji Hospital Ethics Committee of Shanghai Jiao Tong University School of Medicine (KY2019-197).
: Not applicable.
: The authors all declared that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.